Meeting
2019 Gastrointestinal Cancers Symposium
Hypofractionated radiation therapy for unresectable/locally recurrent intrahepatic cholangiocarcinoma.
Authors
Alicia Smart
Harvard Medical School, Boston, MA
Alicia Smart , Theodore S. Hong , Natasa Petkovska , Bridget N. Noe , Andrew X. Zhu , Cristina Ferrone , Kenneth Tanabe , Jill N. Allen , Lorraine C. Drapek , Motaz Qadan , Janet E. Murphy , Lipika Goyal , Jennifer Yon-Li Wo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 412)
DOI
10.1200/JCO.2019.37.4_suppl.412
Abstract #
412
Poster Bd #
M12
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database.
First Author: Lauren E. Schleimer
Poster
2023 ASCO Annual Meeting
The value of progression-free survival at three years as a primary endpoint for studies on radiotherapy in patients with locally advanced cervical cancer: Individual patient data from Chinese National Cancer Center and validation from 27 global randomized trials.
First Author: Xi Yang
Poster
2022 ASCO Gastrointestinal Cancers Symposium
“Super massive” intrahepatic cholangiocarcinoma: Potential role of radiation therapy.
First Author: Joseph Abi Jaoude
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of exposure to clinical trials and standard-of-care therapy in metastatic or recurrent prostate cancer: An update.
First Author: Grace G Kim